SciELO - Scientific Electronic Library Online

 
vol.48 issue3The importance of nutritional intervention in the reduction of body weight in patients with the antiphospholipid antibodyEvaluation of the quantitative and qualitative aspects of pain in the fibromyalgia sydrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Reumatologia

Print version ISSN 0482-5004On-line version ISSN 1809-4570

Abstract

VIEIRA, Walber Pinto et al. Prevalence and follow-up analysis of evolution of severe and moderate neuropsychiatric manifestations in hospitalized systemic lupus erythematosus in the rheumatology service of the Hospital General de Fortaleza. Rev. Bras. Reumatol. [online]. 2008, vol.48, n.3, pp.141-150. ISSN 0482-5004.  https://doi.org/10.1590/S0482-50042008000300003.

OBJECTIVE: Evaluate the prevalence and therapy outcome of moderate and severe neuropsychiatric manifestations (NPM) in patients with systemic lupus erythematosus admitted at the Hospital Geral de Fortaleza. METHODS: During two years, 110 patients with consecutive hospitalizations suffering from systemic lupus erythematosus, according to the American College of Rheumatology criteria, were evaluated for moderate and severe NPM. The following parameters were studied in these patients: cause of admission, presence of auto-antibodies, cerebral spinal fluid, radiological imaging, retrospective study of medical records and treatment. RESULTS: The prevalence of NPM was 16.4% (18/110), being seventeen women and one man; the mean age was 29 years; during the hospitalization term, only 33% (6/18) of the patients had an NPM. The occurrence of the first NPM was in 11% (2/18) of the cases before diagnosis, in 33% (6/18) during diagnosis and in 56% (10/18) after diagnosis. The mortality rate was 11% (2/18). The most common NPM's were: seizures and headache (50%), psychosis (22%), cerebrovascular disease (17%), syncope and major depression (11%). Treatment outcome: 28% (5/18) of the patients responded to oral corticoids, 17% (3/18) had a pulse of methylprednisolone and 56% (10/18) were treated with cyclophosphamide. CONCLUSION: The prevalence of NPM in the patients of this study was on the lowest limit reported by the related literature. With no controlled clinical trials, the approach to these patients is based on case reports and the professional experience of the service.

Keywords : systemic lupus erythematosus; neuropsychiatric manifestations.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License